Diagnostics News and Research

RSS

GE Healthcare announces commercial availability of new Alzheimer’s diagnostic tool

GE Healthcare today announced the first seven markets where Vizamyl (Flutemetamol F18 injection), a radioactive diagnostic agent approved by the FDA will be available. Late in the second quarter of 2014, Vizamyl will be available to imaging centers near East Rutherford, NJ, Woburn, MA, Beltsville, MD, East Lansing, MI, Dallas, TX, Phoenix, AZ and Colton, CA.

29 Apr 2014

Illumina launches VeriSeq PGS for preimplantation genetic screening of embryos

Illumina, Inc. today announced the launch of VeriSeq PGS, a next-generation sequencing solution developed for preimplantation genetic screening of embryos using Illumina's NextSeq 500 and MiSeq® sequencing systems.

From Illumina, Inc. 29 Apr 2014

The rising incidence of multi-drug resistant TB: an interview with Dr Myriam Haxaire-Theeuwes, Compound Development Team Leader, Janssen

MDR-TB is on the rise in a number of regions in the world, because progress towards targets for diagnosis and treatment of multidrug-resistant TB (MDR-TB) is far off-track.

29 Apr 2014

GW University establishes new online integrative medicine program

The George Washington University (GW) School of Medicine and Health Sciences is pleased to announce the establishment of a new, online Integrative Medicine Program, in partnership with the Metabolic Medical Institute.

29 Apr 2014

Single cell type actively suppressed in several experimental cancer vaccines

Most cancer vaccines have not lived up to their promise in clinical trials. The reason, many researchers suspect, is that the immune cells that would help the body destroy the tumor - even those reactions boosted by cancer vaccines - are actively suppressed.

29 Apr 2014

Research team discovers new water-soluble fluorescent system for early detection of cancer cells

A research team lead by Academy Professor Kari Rissanen at the University of Jyväskylä has discovered a new water-soluble fluorescent detection system that is extremely sensitive to pyrophosphate (PPi).

25 Apr 2014

Zenalux, RPCI collaborate to enhance Zenascope system to detect oral cancers at an early stage

Zenalux Biomedical, Inc., a leader in biophotonic diagnostics, is working with Roswell Park Cancer Institute to further enhance its flagship Zenascope™ product by adding a high-resolution camera to the system.

25 Apr 2014

Study shows effect of whooping cough vaccination on Bordetella pertussis bacteria

The most comprehensive study to date of the family of bacteria that causes whooping cough points to more effective vaccine strategies and reveals surprising findings about the bacteria's origin and evolution. The new results could alter public health strategies to control this respiratory disease, which kills 195,000 children worldwide each year.

25 Apr 2014

Roche's cobas HPV Test gets FDA approval for first-line primary screening for cervical cancer

Roche announced today that the U.S. Food and Drug Administration approved the cobas HPV (Human Papillomavirus) Test for use as a first-line primary screening test for cervical cancer in women 25 and older. The approval follows the March 12 unanimous recommendation from the Microbiology Devices Panel of the FDA's Medical Devices Advisory Committee, making the cobas HPV Test the first and only HPV test in the United States approved for first-line primary screening.

From Roche Sequencing and Life Science 25 Apr 2014

Liaison Healthcare's EMR-Link solution recognized as a certified Health IT Quality Solution

As a certified Health IT Quality Solution, Liaison Healthcare's EMR-Link solution has been recognized by Quest Diagnostics as meeting or exceeding advanced industry standards for health IT quality and for providing a streamlined, interoperable solution that enables secure clinical laboratory ordering and results reporting through Quest Diagnostics connectivity solutions.

From Quest Diagnostics 23 Apr 2014

WLSA's Convergence Summit to focus on global adoption of technology-enabled health care

The Wireless-Life Sciences Alliance said today that its ninth annual Convergence Summit here next month will focus on achieving broader global adoption of technology-enabled health care at a time when the pace of innovation in connected health and personal health solutions is accelerating.

23 Apr 2014

Personalis receives CAP accreditation

Personalis, Inc., a leading provider of genome-based diagnostics, announced today that its onsite clinical laboratory has received accreditation from the College of American Pathologists (CAP), meeting the highest standard of excellence in clinical laboratory practices.

23 Apr 2014

AMP releases report on recommendations for molecular diagnostics curriculum

The Association for Molecular Pathology (AMP) released a report today in The Journal of Molecular Diagnostics on recommendations for a molecular diagnostics curriculum at both the baccalaureate and master's levels of education.

23 Apr 2014

Studies identify 2 genes highly associated with IBD

Inflammatory Bowel Disease (IBD), a group of chronic inflammatory disorders of the intestine that result in painful and debilitating complications, affects over 1.4 million people in the U.S., and while there are treatments to reduce inflammation for patients, there is no cure.

23 Apr 2014

Catheter coating: an interview with Dr. Hinke Malda, Director of Medical Coatings, DSM Biomedical

DSM’s biomedical work brings new material innovation to market through the development of novel materials-based solutions that meet the present and future needs of the medical device and pharmaceutical industries.

22 Apr 2014

Automated diagnostic technologies redefine infectious diseases

The diagnostics market for infectious diseases such as tuberculosis (TB), human immunodeficiency virus (HIV), hepatitis C virus and human papilloma virus is expanding, giving rise to commercial opportunities especially in the developing economies of Asia, Africa and Latin America.

22 Apr 2014

Researchers study evolution of harmful organisms from 1 bacterial family

For the first time, researchers have studied the Black Death bacterium's entire family tree to fully understand how some of the family members evolve to become harmful.

22 Apr 2014

New report analyzes Mobile Medical Apps market worldwide

Global Information Inc. announces the addition of a new market research report "Mobile Medical Apps Trends" at GIIResearch.com

21 Apr 2014

Cepheid's revenues increase 16% to 106.9 million in first quarter 2014

Cepheid today reported revenues for the first quarter of 2014 of $106.9 million, representing growth of 16% from $91.9 million for the first quarter of 2013. Net loss in the first quarter of 2014 was $(9.3) million, or $(0.13) per share, which compares to net income of $0.3 million, or $0.00 per share, in the first quarter of 2013.

18 Apr 2014

Global cancer profiling market expected to grow $54.8 billion by 2018

Global Information Inc. announces the addition of a new market research report "Cancer Profiling and Pathways: Technologies and Global Markets" at GIIResearch.com.

18 Apr 2014

Diagnostics News and Research

GE Healthcare announces commercial availability of new Alzheimer’s diagnostic tool

Illumina launches VeriSeq PGS for preimplantation genetic screening of embryos

The rising incidence of multi-drug resistant TB: an interview with Dr Myriam Haxaire-Theeuwes, Compound Development Team Leader, Janssen

GW University establishes new online integrative medicine program

Single cell type actively suppressed in several experimental cancer vaccines

Research team discovers new water-soluble fluorescent system for early detection of cancer cells

Zenalux, RPCI collaborate to enhance Zenascope system to detect oral cancers at an early stage

Study shows effect of whooping cough vaccination on Bordetella pertussis bacteria

Roche's cobas HPV Test gets FDA approval for first-line primary screening for cervical cancer

Liaison Healthcare's EMR-Link solution recognized as a certified Health IT Quality Solution

WLSA's Convergence Summit to focus on global adoption of technology-enabled health care

Personalis receives CAP accreditation

AMP releases report on recommendations for molecular diagnostics curriculum

Studies identify 2 genes highly associated with IBD

Catheter coating: an interview with Dr. Hinke Malda, Director of Medical Coatings, DSM Biomedical

Automated diagnostic technologies redefine infectious diseases

Researchers study evolution of harmful organisms from 1 bacterial family

New report analyzes Mobile Medical Apps market worldwide

Cepheid's revenues increase 16% to 106.9 million in first quarter 2014

Global cancer profiling market expected to grow $54.8 billion by 2018

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News